Diabetes drug has kidney-protective effects in patients with advanced kidney disease
A recent analysis indicates that a drug shown previously to slow kidney disease progression is effective even in patients with […]
A recent analysis indicates that a drug shown previously to slow kidney disease progression is effective even in patients with […] WEDNESDAY, Nov. 18, 2020 — Vitamin D supplementation is associated with a reduction in the incidence of advanced cancer, with […] An electronic nudge to clinicians—triggered by an algorithm that used machine learning methods to flag patients with cancer who would […] THOUSAND OAKS, Calif., Oct. 5, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating […] Object recognition and facial recognition may seem like similar abilities, but new research finds that these behaviors are on the […] (HealthDay)—Following state health reform, there was a decline in advanced-stage colorectal cancer (CRC) diagnoses in Massachusetts, according to a study […] Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and […] London UK – 19 March 2019 — TESARO, an oncology-focused business acquired by GlaxoSmithKline plc (LSE/NYSE: GSK), announced today the presentation […] WEDNESDAY, Jan. 16, 2019 — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with […]Advanced
Diabetes drug has kidney-protective effects in patients with advanced kidney disease
Vitamin D Supplementation Tied to Reduction in Advanced Cancer
Nudges combined with machine learning triples advanced care conversations among patients with cancer
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
Advanced, high-res MRI scans reveal link between cognitive abilities and ‘tree ring’ layers in the brain
Massachusetts health reform tied to decrease in advanced cancer
Advanced breast cancer patients denied access to life-prolonging drugs and opioids
Data From GARNET Study Indicates Robust Activity of Dostarlimab in Patients with Advanced or Recurrent Endometrial Cancer
Adoption of Advanced Health IT Capabilities Inconsistent
Copyright © 2024